BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 21626506)

  • 21. Long-term survival in patients with germ cell testicular cancer: a population-based competing-risks regression analysis.
    Gandaglia G; Becker A; Trinh QD; Abdollah F; Schiffmann J; Roghmann F; Tian Z; Montorsi F; Briganti A; Karakiewicz PI; Sun M
    Eur J Surg Oncol; 2014 Jan; 40(1):103-12. PubMed ID: 24099755
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Maternal smoking and testicular germ cell tumors.
    McGlynn KA; Zhang Y; Sakoda LC; Rubertone MV; Erickson RL; Graubard BI
    Cancer Epidemiol Biomarkers Prev; 2006 Oct; 15(10):1820-4. PubMed ID: 17035387
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Screening for carcinoma in situ in the contralateral testicle in patients with testicular cancer: a population-based study.
    Kier MGG; Lauritsen J; Almstrup K; Mortensen MS; Toft BG; Rajpert-De Meyts E; Skakkebaek NE; Rørth M; von der Maase H; Agerbaek M; Holm NV; Andersen KK; Dalton SO; Johansen C; Daugaard G
    Ann Oncol; 2015 Apr; 26(4):737-742. PubMed ID: 25542924
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Probability of metachronous testicular cancer in patients with biopsy-proven intratubular germ cell neoplasia depends on first-time treatment of germ cell cancer.
    Brabrand S; Fosså SD; Cvancarova M; Axcrona U; Lehne G
    J Clin Oncol; 2012 Nov; 30(32):4004-10. PubMed ID: 23071246
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical characteristics of metachronous bilateral testicular tumors in the chemotherapeutic era.
    Park DS; Prow DM; Amato RJ; Ro JY; Logothetis CJ
    Yonsei Med J; 1999 Apr; 40(2):137-43. PubMed ID: 10333717
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Paternal age and risk of testicular germ cell tumors: a cohort study of 1,000,000 men.
    Levine H; Keinan-Boker L; Leiba A; Derazne E; Rais A; Kark JD
    Andrology; 2017 Nov; 5(6):1124-1130. PubMed ID: 28950439
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Recent trends in the incidence of testicular germ cell tumors in the United States.
    Ghazarian AA; Trabert B; Devesa SS; McGlynn KA
    Andrology; 2015 Jan; 3(1):13-8. PubMed ID: 25331158
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Gene variations in sex hormone pathways and the risk of testicular germ cell tumour: a case-parent triad study in a Norwegian-Swedish population.
    Kristiansen W; Andreassen KE; Karlsson R; Aschim EL; Bremnes RM; Dahl O; Fosså SD; Klepp O; Langberg CW; Solberg A; Tretli S; Adami HO; Wiklund F; Grotmol T; Haugen TB
    Hum Reprod; 2012 May; 27(5):1525-35. PubMed ID: 22402210
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Contralateral testicular cancer in spite of TIN-negative double biopsies and interval cisplatin chemotherapy.
    Souchon R; Gertenbach U; Dieckmann KP; Hahn E; Ruwe M; Stambolis C; Loy V; Classen J
    Strahlenther Onkol; 2006 May; 182(5):289-92. PubMed ID: 16673063
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sperm concentration, testicular volume and age predict risk of carcinoma in situ in contralateral testis of men with testicular germ cell cancer.
    Rud CN; Daugaard G; Rajpert-De Meyts E; Skakkebæk NE; Petersen JH; Jørgensen N
    J Urol; 2013 Dec; 190(6):2074-80. PubMed ID: 23770148
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prospectively Identified Incident Testicular Cancer Risk in a Familial Testicular Cancer Cohort.
    Pathak A; Adams CD; Loud JT; Nichols K; Stewart DR; Greene MH
    Cancer Epidemiol Biomarkers Prev; 2015 Oct; 24(10):1614-21. PubMed ID: 26265202
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Long-term Relative Survival after Diagnosis of Testicular Germ Cell Tumor.
    Kvammen Ø; Myklebust TÅ; Solberg A; Møller B; Klepp OH; Fosså SD; Tandstad T
    Cancer Epidemiol Biomarkers Prev; 2016 May; 25(5):773-9. PubMed ID: 26908435
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Successful treatment of metachronous contralateral intratubular germ cell neoplasia with partial orchiectomy and low-dose radiation in a patient previously treated for testicular carcinoma.
    Schneller N; Grimes A; Muscal J; Quintanilla N; Mittal A; Paulino A; Foster J
    Pediatr Blood Cancer; 2019 Oct; 66(10):e27872. PubMed ID: 31179623
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The impact of adjuvant therapy on contralateral breast cancer risk and the prognostic significance of contralateral breast cancer: a population based study in the Netherlands.
    Schaapveld M; Visser O; Louwman WJ; Willemse PH; de Vries EG; van der Graaf WT; Otter R; Coebergh JW; van Leeuwen FE
    Breast Cancer Res Treat; 2008 Jul; 110(1):189-97. PubMed ID: 17687645
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Population-based study of treatment guided by tumor marker decline in patients with metastatic nonseminomatous germ cell tumor: a report from the Swedish-Norwegian Testicular Cancer Group.
    Olofsson SE; Tandstad T; Jerkeman M; Dahl O; Ståhl O; Klepp O; Bremnes RM; Cohn-Cedermark G; Langberg CW; Laurell A; Solberg A; Stierner U; Wahlqvist R; Wijkström H; Anderson H; Cavallin-Ståhl E
    J Clin Oncol; 2011 May; 29(15):2032-9. PubMed ID: 21482994
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bilateral Testicular Germ Cell Tumors: A Case-Series From a UK-Based Tertiary Referral Center Over 19 Years.
    Watson RA; Morgan RD; Joseph J; Sivakumar S; Verrill C; Tuthill M; Sullivan M; Protheroe AS
    Clin Genitourin Cancer; 2018 Jun; 16(3):e513-e516. PubMed ID: 29566999
    [No Abstract]   [Full Text] [Related]  

  • 37. Bilateral testicular germ cell tumours: a single hospital experience.
    Morales-Barrera R; Valverde C; Rodón J; Pérez J; Maldonado X; Suárez C; Trilla E; Carles J
    Clin Transl Oncol; 2010 Apr; 12(4):299-302. PubMed ID: 20462840
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The incidence and management of metachronous testicular germ cell tumors in patients with extragonadal germ cell tumors.
    Hashimoto K; Fujimoto H; Kouno T; Koseki M; Yonemori K; Hirata T; Yunokawa M; Shimizu C; Katsumata N; Tamura K; Ando M; Takeuchi M; Nakanishi H; Komiyama M; Nakagawa T; Fujiwara Y
    Urol Oncol; 2012; 30(3):319-24. PubMed ID: 20471872
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Treatment outcome of metastatic testicular cancer at a single institution in Japan, a country with low incidence of germ cell tumor.
    Kawai K; Hinotsu S; Oikawa T; Sekido N; Hattori K; Miyanaga N; Hasegawa Y; Kojima H; Shimazui T; Akaza H
    Jpn J Clin Oncol; 2006 Nov; 36(11):723-30. PubMed ID: 17082218
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Risk of second gonadal cancers in women and children with germ cell tumors.
    Liao ZW; Rodrigues MC; Poynter JN; Amatruda JF; Rodriguez-Galindo C; Frazier AL
    Cancer; 2016 Jul; 122(13):2076-82. PubMed ID: 27152727
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.